CLINICAL_TRIALS trial_result · 2011-07-01

Clinical Trial Update: Parkinson's Disease Isradipine Safety Study [Phase 2]

Phase 2 safety study update for isradipine in Parkinson's disease completed with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Northwestern University | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED | Results posted: 2011-07-01